New type 1 diabetes clinical trial underway
JDRF-funded researchers at the University of Queensland have launched a clinical trial into a new blood test they hope will be able to accurately predict people at risk of type 1 diabetes.
The test is the result of research that has identified a link between the onset of type 1 diabetes and a special type of protein called NF-Kappa B. In a healthy immune system, this protein is an important component of the immune response to infection. In people with type 1 diabetes, and seemingly also in people at risk of developing type 1 diabetes, this protein is constantly activated resulting in the autoimmune destruction of the insulin-producing beta cells in the pancreas.
2 Comments 
Breakthrough research by a Sydney-based research team has shown that the amount of dietary fibre in the diet plays a fundamental role in keeping the immune system healthy and autoimmune diseases, such as type 1 diabetes at bay.



